Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies

R. Constantinescu; U. Andreasson; B. Holmberg; H. Zetterberg

doi:10.1111/ane.12012

journal article Sep 23, 2012

Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies

R. Constantinescu U. Andreasson B. Holmberg H. Zetterberg

Acta Neurologica Scandinavica Vol. 127 No. 2 pp. e8-e12 · Hindawi Limited

View at Publisher Save 10.1111/ane.12012

Topics

No keywords indexed for this article. Browse by subject →

References

26

[1]

Olanow "Oxidation reactions in Parkinson's disease" Neurology (1990)

[2]

Davis "Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease" Am J Epidemiol (1996) 10.1093/oxfordjournals.aje.a008954

[3]

Low plasma uric acid level in Parkinson's disease

Tua Annanmaki, Antti Muuronen, Kari Murros

Movement Disorders 2007 10.1002/mds.21502

[4]

Gao "Diet, urate, and Parkinson's disease risk in men" Am J Epidemiol (2008) 10.1093/aje/kwm385

[5]

De Vera "Gout and the risk of Parkinson's disease: a cohort study" Arthritis Rheum (2008) 10.1002/art.24193

[6]

Ascherio "Urate as a predictor of the rate of clinical decline in Parkinson disease" Arch Neurol (2009) 10.1001/archneurol.2009.247

[7]

Annanmaki "Uric acid associates with cognition in Parkinson's disease" Parkinsonism Relat Disord (2008) 10.1016/j.parkreldis.2007.11.001

[8]

Maetzler "Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-beta pathway" J Alzheimers Dis (2011) 10.3233/jad-2011-110587

[9]

Lee "Uric acid as a potential disease modifier in patients with multiple system atrophy" Mov Disord (2011) 10.1002/mds.23556

[10]

Auinger "The relationship between uric acid levels and Huntington's disease progression" Mov Disord (2010) 10.1002/mds.22907

[11]

Euser "Serum uric acid and cognitive function and dementia" Brain (2009)

[12]

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

A J Hughes, S E Daniel, L Kilford et al.

Journal of Neurology, Neurosurgery &amp; Psych... 1992 10.1136/jnnp.55.3.181

[13]

Gilman "Consensus statement on the diagnosis of multiple system atrophy" Clin Auton Res (1998) 10.1007/bf02309628

[14]

Litvan "Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop" Neurology (1996) 10.1212/wnl.47.1.1

[15]

Lang (1994)

[16]

Parkinsonism

Margaret M. Hoehn, Melvin D. Yahr

Neurology 1967 10.1212/wnl.17.5.427

[17]

Tolosa "The diagnosis of Parkinson's disease" Lancet Neurol (2006) 10.1016/s1474-4422(05)70285-4

[18]

Litvan "Recent advances in atypical parkinsonian disorders" Curr Opin Neurol (1999) 10.1097/00019052-199908000-00011

[19]

Jellinger "Neuropathological spectrum of synucleinopathies" Mov Disord (2003) 10.1002/mds.10557

[20]

Holmberg "Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease" Mov Disord (1998) 10.1002/mds.870130116

[21]

Constantinescu "Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease" Parkinsonism Relat Disord (2009) 10.1016/j.parkreldis.2008.05.012

[22]

Niklasson "Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid" Ups J Med Sci (1988) 10.3109/03009738809178548

[23]

O'Neill "Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs" Brain Res (1990) 10.1016/0006-8993(90)90281-f

[24]

Bierer "Effect of L-dopa on renal handling of uric acid" J Pharmacol Exp Ther (1982) 10.1016/s0022-3565(25)33291-x

[25]

Chen "Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study" Am J Epidemiol (2009) 10.1093/aje/kwp033

[26]

Winquist "Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey" Mov Disord (2010) 10.1002/mds.23070

Cited By

19

Low serum uric acid levels in progressive supranuclear palsy

Juan Manuel Oropesa‐Ruiz, Ismael Huertas‐Fernández · 2015

Movement Disorders

Metrics

19

Citations

26

References

Details

Published: Sep 23, 2012
Vol/Issue: 127(2)
Pages: e8-e12
License: View

Authors

R

R. Constantinescu

Department of Neurology; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden

U

U. Andreasson

Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden

B

B. Holmberg

Department of Neurology; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden

H

H. Zetterberg

Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden

Cite This Article

R. Constantinescu, U. Andreasson, B. Holmberg, et al. (2012). Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies. Acta Neurologica Scandinavica, 127(2), e8-e12. https://doi.org/10.1111/ane.12012

Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies

You May Also Like